Ensuring Balance in national policies on controlled substances, guidance for availability and accessibility of controlled medicines

To evaluate policies and regulations in countries with insufficient access to controlled medicines such as opioid analgesics, or opioids to treat dependence (= most countries)

Politique

  • Sous-catégories Evaluation et recherche, Maladie non transmissible (MNT), Santé reproductive, VIH/SIDA
  • Commodities Médicaments
  • Date de mise à jour 2016-03-15 20:11:00
  • Version 1
  • Développé par World Health Organization (Dept EMP)
  • Quand l'utiliser To evaluate policies and regulations in countries with insufficient access to controlled medicines such as opioid analgesics, or opioids to treat dependence (= most countries)
  • Langues Anglais, Espagnol, Français, Russe
  • Niveau d'utilisation Central
  • Forme Introduction with explication of barriers for access to medicines controlled under the drug control conventions: 1. regulations and policies, 2. knowledge 3. attitudes and 4. economic and procurement. Then 21 guidelines on these barriers with examples of
  • Amount of training / TA required None; though good understanding of how public administration works is helpful.
  • Inputs & outputs Working on the checklist with a team with members from the administration and field experts will be the best way to make the assessment from the checklist. This will result in a comprehensive overview of the barriers.
  • Coût All language versions: free download. Hard copies (English, French and Spanish only): CHF 25.00 / US$ 30.00 Developing countries: CHF 17.50
  • Advantages This is an essential tool to overcome the situation that 2/3 of the world pèopulation has no access to adequate management of pain.
  • Contraintes Work load
  • Disponibilité Yes. Please see: http://www.who.int/medicines/areas/quality_safety/guide_nocp_sanend/en/
  • Remarques I am submitting this as the former responsible person in WHO who developed these guidelines. Please see http://www.who.int/medicines/areas/quality_safety/guide_nocp_sanend/en/
  • Contact wk.scholten@xs4all.nl; forteg@who.int
  • Submission date 2016-03-15 02:00:00